~~<i id='EEDE05EE92'><strike id='EEDE05EE92'><tt id='EEDE05EE92'><pre id='EEDE05EE92'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：leisure time 2025-09-06 04:15:09 - browse：455

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Infectious disease expert Jeanne Marrazzo assumes Fauci role

explore

Wikipedia

explore

hotspot

focus

knowledge

LongtimeBluebirdBioCEONickLeschlyWendyMaeda/TheBostonGlobeSometwoyearsaftersplittingbiotechcompanyBl

WSS

Food makers to regulators: Ultra

Micronoma's microbiome cancer diagnostic approach under fire

New safety details link Apellis eye drug to rare cases of blindness

What the airline industry can learn from medicine

How medical schools plan to diversify without affirmative action

Sage hopes for a blockbuster in antidepressant now before FDA

hotspot

fashion

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Wildfire pollution widens asthma inequities on Long Island

What does generative AI mean for health care? We asked experts

Mitch McConnell episode has important public health takeaway

Dobbs anniversary: the lost opportunity of abortion as health care

Popular nasal decongestant doesn't actually relieve congestion

How to save PrEP access — and even expand it

Pig kidney works a record two months in donated body

As demand for Covid shots wanes, Moderna seeks its next success

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Wikipedia

Micronoma's microbiome cancer diagnostic approach under fire

Wildfire pollution widens asthma inequities on Long Island

Food makers to regulators: Ultra

National panel will explore requiring free Covid tests

FDA proposes changes to key medical devices approval pathway

White House touts steps to stem shortages of cancer treatments

explore

hotspot

focus

knowledge